drugset / Trial / NCT01944683

A Double-Blind Pharmacokinetic Interaction Study Evaluating the Effect of a Single IV Infusion of GGF2 or Placebo on Midazolam Pharmacokinetics in Patients With Heart Failure

NCT01944683 ↗

Phase 1 Completed 22 enrolled Acorda Therapeutics
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The study will examine midazolam pharmacokinetics following single dose administration of 3 planned dose levels of GGF2 .

Timeline

Start
2013-09
Primary completion
2016-05
Completion
2016-07

Drugs

EvaluationDrugModalityDoseRoute
Subject GGF2 Protein / enzyme biologic — Intravenous
Subject Midazolam Small molecule — Oral

Indications